brexpiprazole
Selected indexed studies
- Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study. (Alzheimers Dement, 2024) [PMID:39369280]
- Brexpiprazole. (, 2012) [PMID:31643783]
- Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial. (JAMA Neurol, 2023) [PMID:37930669]
_Worker-drafted node — pending editorial review._
Connections
brexpiprazole is a side effect of
Sources
- Brexpiprazole and Sertraline Combination Treatment in Posttraumatic Stress Disorder: A Phase 3 Randomized Clinical Trial. (2025) pubmed
- Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study. (2024) pubmed
- Brexpiprazole. (2012) pubmed
- Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial. (2023) pubmed
- Brexpiprazole. (2017) pubmed
- Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials. (2024) pubmed
- Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease. (2024) pubmed
- Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials. (2020) pubmed
- Brexpiprazole-Pharmacologic Properties and Use in Schizophrenia and Mood Disorders. (2023) pubmed
- Brexpiprazole: A Review in Schizophrenia. (2019) pubmed